S&P 500   4,278.86 (-0.61%)
DOW   34,011.03 (-0.41%)
QQQ   328.94 (-1.01%)
AAPL   174.89 (+1.07%)
MSFT   291.61 (-0.38%)
META   175.74 (-2.08%)
GOOGL   120.01 (-1.39%)
AMZN   142.46 (-1.60%)
TSLA   912.82 (-0.75%)
NVDA   183.76 (-2.66%)
NIO   20.25 (-3.16%)
BABA   90.12 (-2.73%)
AMD   98.24 (-1.96%)
MU   61.58 (-3.57%)
T   18.47 (-0.54%)
CGC   4.03 (+6.61%)
F   16.08 (-2.13%)
GE   79.80 (-1.57%)
DIS   123.15 (-1.45%)
AMC   22.31 (-10.08%)
PYPL   99.94 (-2.10%)
PFE   49.37 (-0.98%)
NFLX   241.71 (-1.62%)
S&P 500   4,278.86 (-0.61%)
DOW   34,011.03 (-0.41%)
QQQ   328.94 (-1.01%)
AAPL   174.89 (+1.07%)
MSFT   291.61 (-0.38%)
META   175.74 (-2.08%)
GOOGL   120.01 (-1.39%)
AMZN   142.46 (-1.60%)
TSLA   912.82 (-0.75%)
NVDA   183.76 (-2.66%)
NIO   20.25 (-3.16%)
BABA   90.12 (-2.73%)
AMD   98.24 (-1.96%)
MU   61.58 (-3.57%)
T   18.47 (-0.54%)
CGC   4.03 (+6.61%)
F   16.08 (-2.13%)
GE   79.80 (-1.57%)
DIS   123.15 (-1.45%)
AMC   22.31 (-10.08%)
PYPL   99.94 (-2.10%)
PFE   49.37 (-0.98%)
NFLX   241.71 (-1.62%)
S&P 500   4,278.86 (-0.61%)
DOW   34,011.03 (-0.41%)
QQQ   328.94 (-1.01%)
AAPL   174.89 (+1.07%)
MSFT   291.61 (-0.38%)
META   175.74 (-2.08%)
GOOGL   120.01 (-1.39%)
AMZN   142.46 (-1.60%)
TSLA   912.82 (-0.75%)
NVDA   183.76 (-2.66%)
NIO   20.25 (-3.16%)
BABA   90.12 (-2.73%)
AMD   98.24 (-1.96%)
MU   61.58 (-3.57%)
T   18.47 (-0.54%)
CGC   4.03 (+6.61%)
F   16.08 (-2.13%)
GE   79.80 (-1.57%)
DIS   123.15 (-1.45%)
AMC   22.31 (-10.08%)
PYPL   99.94 (-2.10%)
PFE   49.37 (-0.98%)
NFLX   241.71 (-1.62%)
S&P 500   4,278.86 (-0.61%)
DOW   34,011.03 (-0.41%)
QQQ   328.94 (-1.01%)
AAPL   174.89 (+1.07%)
MSFT   291.61 (-0.38%)
META   175.74 (-2.08%)
GOOGL   120.01 (-1.39%)
AMZN   142.46 (-1.60%)
TSLA   912.82 (-0.75%)
NVDA   183.76 (-2.66%)
NIO   20.25 (-3.16%)
BABA   90.12 (-2.73%)
AMD   98.24 (-1.96%)
MU   61.58 (-3.57%)
T   18.47 (-0.54%)
CGC   4.03 (+6.61%)
F   16.08 (-2.13%)
GE   79.80 (-1.57%)
DIS   123.15 (-1.45%)
AMC   22.31 (-10.08%)
PYPL   99.94 (-2.10%)
PFE   49.37 (-0.98%)
NFLX   241.71 (-1.62%)
ETR:FME

Fresenius Medical Care AG & Co. KGaA - FME Price Target & Analyst Ratings

€37.30
+0.60 (+1.63%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
€36.78
€37.69
50-Day Range
€35.83
€54.16
52-Week Range
€35.08
€69.96
Volume
597,628 shs
Average Volume
704,197 shs
Market Capitalization
$10.94 billion
P/E Ratio
13.56
Dividend Yield
3.68%
Price Target
€52.15

Fresenius Medical Care AG & Co. KGaA Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

€52.15
High Prediction€75.00
Average Prediction€52.15
Low Prediction€23.00
TypeCurrent
8/17/21 to 8/17/22
1 Month Ago
7/18/21 to 7/18/22
3 Months Ago
5/19/21 to 5/19/22
1 Year Ago
8/17/20 to 8/17/21
Consensus RatingN/AN/A
Hold
Hold
Strong Buy N/A N/A
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy N/A N/A
1 Buy rating(s)
6 Buy rating(s)
Hold N/A N/A
0 Hold rating(s)
6 Hold rating(s)
Sell N/A N/A
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target€52.15€65.40€65.22€70.56
Get Fresenius Medical Care AG & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.


FME Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FME Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fresenius Medical Care AG & Co. KGaA Stock vs. The Competition

TypeFresenius Medical Care AG & Co. KGaAMedical Companies
Consensus Rating Score
0.00
2.70
Consensus RatingN/ABuy
News Sentiment RatingPositive News
Positive News
MarketBeat
Community Rating
Outperform Votes
1049
69.89%
Underperform Votes
452
30.11%
Avg. Outperform Votes
167
66.80%
Avg. Underperform Votes
83
33.20%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/8/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Tom Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€57.95+57.00%
8/5/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christoph Gretler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€47.00+29.55%
8/5/2022Warburg Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christian Ehmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€42.00+15.77%
8/5/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Hassan Al-Wakeel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€40.00+10.25%
8/2/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Falko Friedrichs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€37.00+3.27%
7/29/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Graham Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€38.00+1.52%
7/29/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Adlington
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€23.00-38.55%
7/25/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
James Vane-Tempest
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€64.00+43.21%
3/22/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Dubajova Veronika
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€71.00+19.41%
2/4/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Grigat Daniel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€60.00-1.48%
1/10/2022Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reinberg Oliver
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€59.00+4.42%
11/5/2021Nord/LB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Fechner Holger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€75.00+26.56%
11/2/2021Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Bedell Clive Lisa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€64.00+8.66%
7/14/2021Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jüngling Michael
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€75.00+6.41%
2/25/2021Independent Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetBuy€71.00+22.71%
11/18/2019HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetBuy€78.00+18.36%
11/1/2019Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetBuy€85.00+28.48%
(Data available from 8/17/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












FME Price Target - Frequently Asked Questions

Do MarketBeat users like Fresenius Medical Care AG & Co. KGaA more than its competitors?

MarketBeat users like Fresenius Medical Care AG & Co. KGaA more than other Medical companies. 69.89% of MarketBeat users gave Fresenius Medical Care AG & Co. KGaA an outperform vote while medical companies recieve an average of 66.80% outperform votes by MarketBeat users.

Does Fresenius Medical Care AG & Co. KGaA's stock price have much upside?

According to analysts, Fresenius Medical Care AG & Co. KGaA's stock has a predicted upside of 13.72% based on their 12-month price targets.

What analysts cover Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA has been rated by Barclays, Berenberg Bank, Credit Suisse Group, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., UBS Group, and Warburg Research in the past 90 days.


Stock Ratings Reports and Tools

This page (ETR:FME) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.